Neuroblastoma in a 55-year-old patient: A case report

Case Reports in Oncology

Volumn 3, Issue 3, 2010, Pages 458-462

  Then, Cornelia ^a   Ebelt, Kathleen ^a   Langer, Alexandra ^a   Mayr, Doris ^b   Schmidmaier, Ralf ^a   Oduncu, Fuat ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chemotherapy; Multiple myeloma; Neuroblastoma; Response to treatment

Indexed keywords

(3 IODOBENZYL)GUANIDINE; CISPLATIN; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE; VINDESINE;

ADULT; ADVANCED CANCER; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER THERAPY; CASE REPORT; DIAGNOSTIC ERROR; DRUG MEGADOSE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NEUROBLASTOMA; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; TREATMENT RESPONSE;

EID: 78751554570     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000322863     Document Type: Article

References (15)

1. London WB, Boni L, Simon T, Berthold F, Twist C, Schmidt ML, Castleberry RP, Matthay KK, Cohn SL, De Bernardi B: The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives. Cancer Lett 2005;228:257-266.
2. Zerrweck-LÓez C, Quijano-Orvañnos F, Montañz- Ramíez H, Murillo-Zolezzi A, Toledo-Valdovinos S, Padilla-Longoria R: Neuroblastoma in the adult. Case report. Cir Cir 2009;77:397-401.
3. Urios JI, Garceran LR, Rosell TV: Neuroblastoma in an adult causing spinal cord compression: report of a case and review of the literature. Paraplegia 1989;27:394-401.
4. Allan SG, Cornbleet MA, Carmichael J, Arnott SJ, Smyth JF: Adult neuroblastoma. Report of three cases and review of the literature. Cancer 1986;57:2419-2421.
5. Conte M, De Bernardi B, Milanaccio C, Michelazzi A, Rizzo A, Montobbio G, Parodi S, Haupt R: Malignant neuroblastic tumors in adolescents. Cancer Lett 2005;228:271-274.
6. Franks LM, Bollen A, Seeger RC, Stram DO, Matthay KK: Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer 1997;79:2028-2035.
7. Moon SB, Park KW, Jung SE, Youn WJ: Neuroblastoma: treatment outcome after incomplete resection of primary tumors. Pediatr Surg Int 2009;25:789-793.
8. George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, Pulsipher M, Grupp SA, Diller L: High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J Clin Oncol 2006;24:2891-2896.
9. Cheung NK, Sowers R, Vickers AJ, Cheung IY, Kushner BH, Gorlick R: FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor. J Clin Oncol 2006;24:2885-2890.
10. Dauer LT, St Germain J, Williamson MJ, Zanzonico P, Modak S, Cheung NK, Divgi C: Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma. Health Phys 2007;92:33-39.
11. Lessig MK: The role of 131I-MIBG in high-risk neuroblastoma treatment. J Pediatr Oncol Nurs 2009;26:208-216.
12. George RE, Diller L, Bernstein ML: Pharmacotherapy of neuroblastoma. Expert Opin Pharmacother 2010.
13. Gustafson WC, Weiss WA: Myc proteins as therapeutic targets. Oncogene 2010;29:1249-1259.
14. Ohnuma-Ishikawa K, Morio T, Yamada T, Sugawara Y, Ono M, Nagasawa M, Yasuda A, Morimoto C, Ohnuma K, Dang NH, Hosoi H, Verdin E, Mizutani S: Knockdown of XAB2 enhances all-trans retinoic acidinduced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells. Cancer Res 2007;67:1019-1029.
15. Lu QY, Wang Z, Li P, Niu XQ, Zhang P, Zhao JN: Treatment of stage IV neuroblastoma with allogeneic hematopoietic stem cell transplantation in children. Zhongguo Dang Dai Er Ke Za Zhi 2008;10:464-466.